Pegcetacoplan for treating primary complement 3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]

  • In development
  • GID-TA11633
  • Expected publication date: 

24302-Pegcetacoplan-for-C3-Glomerulopathy-or-Immune-Complex-Membranoproliferative-Glomerulonephritis-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)